192 results on '"Kakkola, Laura"'
Search Results
2. Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
3. Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
4. Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2
5. Rapid high-throughput compatible label-free virus particle quantification method based on time-resolved luminescence
6. Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.
7. Virus-specific Dicer-substrate siRNA swarms inhibit SARS-CoV-2 infection in TMPRSS2-expressing Vero E6 cells.
8. Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
9. The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base— reveals significant changes in host cell protein expression and activation by multiple SARS-CoV-2 variants
10. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
11. High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages.
12. Influenza A Viruses (Orthomyxoviridae)
13. Emerging Microbes, Infections, and Spillovers: Charting a Path Forward
14. Interaction of Ebola Virus with the Innate Immune System
15. Novel activities of safe-in-human broad-spectrum antiviral agents
16. Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
17. VP24 matrix proteins of eight filoviruses downregulate innate immune response by inhibiting the interferon-induced pathway
18. Ebolavirus protein VP24 interferes with innate immune responses by inhibiting interferon-λ1 gene expression
19. Production, purification and immunogenicity of recombinant Ebola virus proteins − A comparison of Freund’s adjuvant and adjuvant system 03
20. Protein profiling of nasopharyngeal aspirates of hospitalized and outpatients revealed cytokines associated with severe influenza A(H1N1)pdm09 virus infections: A pilot study
21. Asian and African lineage Zika viruses show differential replication and innate immune responses in human dendritic cells and macrophages
22. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
23. Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
24. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
25. Image-based & machine learning-guided multiplexed serology test for SARS-CoV-2
26. Molecular evolution and epidemiology of echovirus 6 in Finland
27. Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection
28. Emerging cellular targets for influenza antiviral agents
29. Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood
30. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination
31. Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
32. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination
33. Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
34. Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood
35. Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study
36. Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation
37. Comparative analysis of BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 vaccine induced antibody responses and the 3rd BNT162b2 vaccine induced neutralizing antibodies against Delta and Omicron variants
38. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
39. Ebola and Marburg virus proteins effectively interfere with the activation of TLR and RIG-I signaling pathways: ID: 71
40. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells
41. Expression of all six human Torque teno virus (TTV) proteins in bacteria and in insect cells, and analysis of their IgG responses
42. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones
43. Comparison of Zaire ebolavirus realtime RT-PCRs targeting the nucleoprotein gene
44. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics
45. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
46. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics
47. COVID-19 mRNA vaccine induced antibody responses and neutralizing antibodies against three SARS-CoV-2 variants
48. Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods
49. Immunology of human erythrovirus infection
50. Construction and biological activity of a full-length molecular clone of human Torque teno virus (TTV) genotype 6
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.